As I slowly digest all of the company's announcements, the more I think OSL is unvdervalued. Enigma Therapeuctics has spent $25 million over 10 years developing Oncosil. The technology is quite advanced really. There had been 4 clinical trials done, 2 on pancreatic cancer and 2 on liver cancer. Similar bios on the ASX at that stage of development have market caps of $30 million at least.
worth a punt, page-3
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.5¢ | 1.4¢ | $109.1K | 7.724M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1864964 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 3579030 | 11 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |